(Total Views: 637)
Posted On: 05/02/2025 10:51:55 PM
Post# of 153011
Nov 16, 2021 -- Health Canada Authorizes Emergency Use of Leronlimab for Treatment of First Triple-Negative Breast Cancer Patient in Canada
"....today announced that Health Canada authorized the emergency use of leronlimab for the treatment of a patient with metastatic triple-negative breast cancer (mTNBC).
“We now plan to ask Health Canada to allow expanded access use for all mTNBC patients who might have no other treatment options. We are also seeking similar approvals in other countries and look forward to providing leronlimab for mTNBC patients, as well as for treatment of other solid tumor cancers...."
Shout out to Mission-Paint-8000 for bringing this up today.
https://www.reddit.com/r/Livimmune/comments/1...for_mtnbc/
So were there more Expanded Access mTNBC trials in Canada yet to hear about ???
Did the CEO/CRO DOJ trial give Cytodyn leads into Canadian trials & too being validated ??
"....today announced that Health Canada authorized the emergency use of leronlimab for the treatment of a patient with metastatic triple-negative breast cancer (mTNBC).
“We now plan to ask Health Canada to allow expanded access use for all mTNBC patients who might have no other treatment options. We are also seeking similar approvals in other countries and look forward to providing leronlimab for mTNBC patients, as well as for treatment of other solid tumor cancers...."
Shout out to Mission-Paint-8000 for bringing this up today.
https://www.reddit.com/r/Livimmune/comments/1...for_mtnbc/
So were there more Expanded Access mTNBC trials in Canada yet to hear about ???
Did the CEO/CRO DOJ trial give Cytodyn leads into Canadian trials & too being validated ??
(5)
(0)Scroll down for more posts ▼
